To undertake a literature review and meta-analysis of the existing studies, attempting to demonstrate the superiority of salicylates or corticosteroids in preventing the sequelae of active carditis valvular heart disease.
The question of whether corticosteroid therapy is marginally superior to salicylates for the prevention of valvular disease from rheumatic fever remains open.
CRD commentary
By limiting the literature search to two sources some relevant studies may have been omitted. The inclusion criteria for studies were defined but there were no details of the methods used to either select the studies or to extract the data. The main outcome assessed was the presence of an apical systolic murmur, but although the authors mentioned that this auscultatory outcome may be less than satisfactory, there was no consideration given to measuring the agreement between assessors. The authors acknowledged that a more sensitive means of detecting carditis, such as echocardiography, may improve the definition of carditis but highlighted the lack of such facilities in developing countries where rheumatic fever is a significant health problem. The authors stated in the discussion that the lack of homogeneity between studies may make aggregation of the trials questionable.
The authors suggested possible sources for the heterogeneity, e.g. differences in patient populations, differences in dosing regimes and bias in observation of the outcome, but concluded that the reasons remain unclear. In view of this heterogeneity, it would have been helpful to have had baseline comparisons of patient characteristics including severity of disease, concurrent therapy and time from onset of illness to intervention. Other problems with the primary studies included the following: a lack of blinding, though this is stated as being impossible given the nature of the interventions; the cushioned side-effects of the steroid; inadequately powered studies; analysis not based on the intention to treat principle; and the transfer of patients allocated to salicylates to steroid treatment. In view of the withdrawals it may have been justified to repeat the analysis using a worst scenario assumption. [A: However, we do not feel that intent to treat analyses on the part of the investigators would have affected the results very much since there were few lost to follow-up or crossed over]. The quality of the included studies was assessed but results of this assessment and details of the methodology were not reported.
In summary: the literature search was limited; there was insufficient detail given of the primary studies, and the methodology used to select studies, extract data and assess quality; unnaccounted for heterogeneity between studies; a lack of intention to treat analysis; and the trials were conducted between 1955 and 1965. Given these factors, the question of the superiority of steroids or salicylates remains unanswered.
